Evidence map›Paper›PMID 9665482›Full record

ArticleThe American journal of pathology1998

Characterization of keratinocyte growth factor and receptor expression in human pancreatic cancer.

T Ishiwata, H Friess, M W Büchler, M E Lopez, M Korc

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 93 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. N-cadherin-mediated adhesion and signaling from development to disease: lessons from mice.Progress in molecular biology and translational science · 2013
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Monoclonal antibodies to fibroblast growth factor receptor 2 effectively inhibit growth of gastric tumor xenografts.Clinical cancer research : an official journal of the American Association for Cancer Research · 2010
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

T IshiwataDepartment of Medicine, University of California, Irvine 92697, USA.
H Friess
M W Büchler
M E Lopez
M Korc
University of Bern · CH

Funding

NCI NIH HHS CA-40962
6 · The paper itself

Abstract

Keratinocyte growth factor (KGF) is an angiogenic and mitogenic polypeptide that has been implicated in cancer growth and tissue development and repair. Its actions are dependent on its binding to a specific cell-surface KGF receptor (KGFR), which is encoded by the fibroblast growth factor (FGF) receptor type II (FGFR-2) gene. In the present study, we compared the immunohistochemical localization of KGF and KGFR/FGFR-2 in the normal and cancerous pancreas using specific antibodies that recognize KGF and KGFR/FGFR-2 and examined the expression of KGF, KGFR, and FGFR-2 in human pancreatic cancer by in situ hybridization with the corresponding riboprobes. In the normal pancreas, KGF immunoreactivity was present principally in the islet cells, whereas KGFR/FGFR-2 immunoreactivity was present both in the islet and ductal cells. In the pancreatic cancers, moderate KGF and moderate to strong KGFR/FGFR-2 immunoreactivity was present in many of the cancer cells. Furthermore, the ductal and acinar cells adjacent to the cancer cells exhibited moderate to strong KGF and KGFR/FGFR-2 immunoreactivity. By in situ hybridization, KGF, KGFR, and FGFR-2 were overexpressed and co-localized in the cancer cells within the pancreatic tumor mass but were even more abundant in the acinar and ductal cells adjacent to the cancer cells. These findings indicate that KGF, KGFR, and FGFR-2 are overexpressed in both the cancer cells and the adjacent pancreatic parenchyma and raise the possibility that KGF may act in an autocrine and paracrine manner to enhance pancreatic cancer cell growth in vivo.

Indexed as

Fibroblast Growth FactorsFibroblast Growth Factor 10Fibroblast Growth Factor 7Growth SubstancesHumansImmunoblottingImmunoenzyme TechniquesIn Situ HybridizationPancreasPancreatic NeoplasmsReceptor, Fibroblast Growth Factor, Type 2Receptor Protein-Tyrosine KinasesReceptors, Fibroblast Growth FactorReceptors, Growth FactorRNA, MessengerTumor Cells, CulturedFGF7 protein, humanFGFR2 protein, humanFibroblast Growth Factor 10Fibroblast Growth Factor 7Fibroblast Growth FactorsGrowth Substanceskeratinocyte growth factor receptorReceptor, Fibroblast Growth Factor, Type 2Receptor Protein-Tyrosine KinasesReceptors, Fibroblast Growth FactorReceptors, Growth FactorRNA, Messenger

Identifiers

PMID9665482
PMCPMC1852955
OpenAlexW2016156871

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.